While OWS whines, Real Capitalists Work To Cure Diseases

Discussion in 'News / Current Events' started by Bro. Curtis, Oct 18, 2011.

  1. Bro. Curtis

    Bro. Curtis
    Expand Collapse
    <img src =/curtis.gif>

    Joined:
    Oct 25, 2001
    Messages:
    20,264
    Likes Received:
    4
  2. kyredneck

    kyredneck
    Expand Collapse
    Well-Known Member

    Joined:
    Jul 28, 2009
    Messages:
    10,566
    Likes Received:
    276
    "The vaccine’s developers hope to use the results of the study to win regulatory approval for the RTS,S and make the vaccine available as soon as 2015. GSK has pledged to sell it at an affordable price (charging just 5 percent above cost), to use any profit to develop a second-generation malaria vaccine and to conduct research on other diseases that plague the developing world, as well as to work with suppliers to reduce the cost.

    Our intention is to supply this vaccine at the lowest cost possible,” said Andrew Witty, GSK’s chief executive officer. “We have no intention of making a profit here.”"

    Cool. Thanks for sharing. This is great news!
     
  3. billwald

    billwald
    Expand Collapse
    Banned

    Joined:
    Jun 28, 2000
    Messages:
    11,414
    Likes Received:
    0
    How is "above cost" defined?
     
  4. Max Fenster

    Max Fenster
    Expand Collapse
    New Member

    Joined:
    Apr 5, 2011
    Messages:
    52
    Likes Received:
    0
    If I were a stockholder, I think I'd sue for fiduciary malpractice.
     

Share This Page

Loading...